Global Nanoemulsions 麻豆原创 Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030

Publication ID:

PB505246690

Publication Date:

June 4, 2024

Pages:

134

Publisher:

MRRPB5

Countries:

Global [1]

USD 5,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Emulsion is the process of suspension of small globules of one liquid into other such that the fluids are immiscible with each other. Nanoemulsions are the group of dispersed nano-particles of oil in water having extremely minute size of 100-600 nm. The nanoemulsions are prepared using various emulsification techniques such as microfluidization, high-pressure homogenization and sonication (use of ultrasound energy).
There are several advantages of nanoemulsions over the conventional emulsion systems. One of the major advantages is the extreme micro droplet size of nanoemulsions with much high surface area which makes them highly effective in transportation system or delivery systems used majorly in cosmetics. Moreover, nanoparticles do not cause the problems such as flocculation, coalescence or inherent creaming which are generally faced by microemulsions. This makes nanoemulsions ideal for variety of formulations such creams, sprays and foams.

Considering the extreme small size of these particles, the nanoemulsions are increasingly finding application in pharmaceutical industry, cosmetic industry and also in food sector. The pharmaceutical applications of nanoemulsions majorly dominate the nanoemulsions market, followed by the cosmetic usages. Currently, the market for nanoemulsions is dominated by North America and Europe. Asia Pacific is the fastest growing market for nanoemulsions.
The global market for Nanoemulsions was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
In USA, EU, Japan, China, India and Southeast Asia, Nanoemulsions key players include Allergan plc, AbbVie Inc., AstraZeneca Inc., Fresenius Kabi AG, etc.
USA is the largest market, with a share over 35%, followed by Europe, and Japan, both have a share about 40 percent.
In terms of application, the largest application is Pharmaceutical Industrial, with a share over 45%, followed by Cosmetic Industrial, Food Industrial, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Nanoemulsions, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Nanoemulsions.
The Nanoemulsions market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nanoemulsions market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nanoemulsions companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
麻豆原创 Segmentation
By Company
Allergan plc
AbbVie Inc.
AstraZeneca Inc.
Fresenius Kabi AG
Kaken Pharmaceutical
GlaxoSmithKline
Novartis AG
Sanofi
B. Braun Melsungen
Segment by Type
Steroids
Anesthetics
NSAIDs
Immunosuppressant
Antiretroviral
Antimicrobials
Vasodilators
Others
Segment by Application
Pharmaceutical Industrial
Cosmetic Industrial
Food Industrial
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Nanoemulsions in global and regional level.
Chapter 3: Detailed analysis of Nanoemulsions company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nanoemulsions revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Study Coverage
1.1 Nanoemulsions Product Introduction
1.2 麻豆原创 by Type
1.2.1 Global Nanoemulsions 麻豆原创 Size Growth Rate by Type (2019 VS 2023 VS 2030)
1.2.2 Steroids
1.2.3 Anesthetics
1.2.4 NSAIDs
1.2.5 Immunosuppressant
1.2.6 Antiretroviral
1.2.7 Antimicrobials
1.2.8 Vasodilators
1.2.9 Others
1.3 麻豆原创 by Application
1.3.1 Global Nanoemulsions 麻豆原创 Size Growth Rate by Application (2019 VS 2023 VS 2030)
1.3.2 Pharmaceutical Industrial
1.3.3 Cosmetic Industrial
1.3.4 Food Industrial
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Nanoemulsions 麻豆原创 Size Estimates and Forecasts
2.2 Nanoemulsions 麻豆原创 Size by Region: 2023 Versus 2030
2.2.1 Global Nanoemulsions Revenue by Region: 2019-2024
2.2.2 Global Nanoemulsions Revenue Forecast by Region (2025-2030)
2.2.3 Global Nanoemulsions Revenue 麻豆原创 Share by Region (2019-2030)
3 Global Nanoemulsions by Company
3.1 Global Nanoemulsions Revenue by Company (2019-2024)
3.2 Global Nanoemulsions Revenue Share by Company (2019-2024)
3.3 Competitive Landscape
3.3.1 Key Nanoemulsions Companies around the World: Ranking by Revenue
3.3.2 Global Nanoemulsions 麻豆原创 Concentration Ratio (CR5 and HHI) & (2019-2024)
3.3.3 Global Nanoemulsions 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.4 Global Nanoemulsions Companies Headquarters & Product Type
3.4.1 Nanoemulsions Companies Headquarters
3.4.2 Global Nanoemulsions Companies Product & Service
3.4.3 Date of International Companies Enter into Nanoemulsions 麻豆原创
3.5 Global Nanoemulsions Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Allergan plc
4.1.1 Allergan plc Company Information
4.1.2 Allergan plc Description, Business Overview
4.1.3 Allergan plc Nanoemulsions Products Offered
4.1.4 Allergan plc Nanoemulsions Revenue and Gross Margin (2019-2024)
4.1.5 Allergan plc Nanoemulsions Revenue by Product in 2023
4.1.6 Allergan plc Nanoemulsions Revenue by Application in 2023
4.1.7 Allergan plc Nanoemulsions Revenue by Geographic Area in 2023
4.1.8 Allergan plc Recent Developments
4.2 AbbVie Inc.
4.2.1 AbbVie Inc. Company Information
4.2.2 AbbVie Inc. Description, Business Overview
4.2.3 AbbVie Inc. Nanoemulsions Products Offered
4.2.4 AbbVie Inc. Nanoemulsions Revenue and Gross Margin (2019-2024)
4.2.5 AbbVie Inc. Nanoemulsions Revenue by Product in 2023
4.2.6 AbbVie Inc. Nanoemulsions Revenue by Application in 2023
4.2.7 AbbVie Inc. Nanoemulsions Revenue by Geographic Area in 2023
4.2.8 AbbVie Inc. Recent Developments
4.3 AstraZeneca Inc.
4.3.1 AstraZeneca Inc. Company Information
4.3.2 AstraZeneca Inc. Description, Business Overview
4.3.3 AstraZeneca Inc. Nanoemulsions Products Offered
4.3.4 AstraZeneca Inc. Nanoemulsions Revenue and Gross Margin (2019-2024)
4.3.5 AstraZeneca Inc. Nanoemulsions Revenue by Product in 2023
4.3.6 AstraZeneca Inc. Nanoemulsions Revenue by Application in 2023
4.3.7 AstraZeneca Inc. Nanoemulsions Revenue by Geographic Area in 2023
4.3.8 AstraZeneca Inc. Recent Developments
4.4 Fresenius Kabi AG
4.4.1 Fresenius Kabi AG Company Information
4.4.2 Fresenius Kabi AG Description, Business Overview
4.4.3 Fresenius Kabi AG Nanoemulsions Products Offered
4.4.4 Fresenius Kabi AG Nanoemulsions Revenue and Gross Margin (2019-2024)
4.4.5 Fresenius Kabi AG Nanoemulsions Revenue by Product in 2023
4.4.6 Fresenius Kabi AG Nanoemulsions Revenue by Application in 2023
4.4.7 Fresenius Kabi AG Nanoemulsions Revenue by Geographic Area in 2023
4.4.8 Fresenius Kabi AG Recent Developments
4.5 Kaken Pharmaceutical
4.5.1 Kaken Pharmaceutical Company Information
4.5.2 Kaken Pharmaceutical Description, Business Overview
4.5.3 Kaken Pharmaceutical Nanoemulsions Products Offered
4.5.4 Kaken Pharmaceutical Nanoemulsions Revenue and Gross Margin (2019-2024)
4.5.5 Kaken Pharmaceutical Nanoemulsions Revenue by Product in 2023
4.5.6 Kaken Pharmaceutical Nanoemulsions Revenue by Application in 2023
4.5.7 Kaken Pharmaceutical Nanoemulsions Revenue by Geographic Area in 2023
4.5.8 Kaken Pharmaceutical Recent Developments
4.6 GlaxoSmithKline
4.6.1 GlaxoSmithKline Company Information
4.6.2 GlaxoSmithKline Description, Business Overview
4.6.3 GlaxoSmithKline Nanoemulsions Products Offered
4.6.4 GlaxoSmithKline Nanoemulsions Revenue and Gross Margin (2019-2024)
4.6.5 GlaxoSmithKline Nanoemulsions Revenue by Product in 2023
4.6.6 GlaxoSmithKline Nanoemulsions Revenue by Application in 2023
4.6.7 GlaxoSmithKline Nanoemulsions Revenue by Geographic Area in 2023
4.6.8 GlaxoSmithKline Recent Development
4.7 Novartis AG
4.7.1 Novartis AG Company Information
4.7.2 Novartis AG Description, Business Overview
4.7.3 Novartis AG Nanoemulsions Products Offered
4.7.4 Novartis AG Nanoemulsions Revenue and Gross Margin (2019-2024)
4.7.5 Novartis AG Nanoemulsions Revenue by Product in 2023
4.7.6 Novartis AG Nanoemulsions Revenue by Application in 2023
4.7.7 Novartis AG Nanoemulsions Revenue by Geographic Area in 2023
4.7.8 Novartis AG Recent Development
4.8 Sanofi
4.8.1 Sanofi Company Information
4.8.2 Sanofi Description, Business Overview
4.8.3 Sanofi Nanoemulsions Products Offered
4.8.4 Sanofi Nanoemulsions Revenue and Gross Margin (2019-2024)
4.8.5 Sanofi Nanoemulsions Revenue by Product in 2023
4.8.6 Sanofi Nanoemulsions Revenue by Application in 2023
4.8.7 Sanofi Nanoemulsions Revenue by Geographic Area in 2023
4.8.8 Sanofi Recent Development
4.9 B. Braun Melsungen
4.9.1 B. Braun Melsungen Company Information
4.9.2 B. Braun Melsungen Description, Business Overview
4.9.3 B. Braun Melsungen Nanoemulsions Products Offered
4.9.4 B. Braun Melsungen Nanoemulsions Revenue and Gross Margin (2019-2024)
4.9.5 B. Braun Melsungen Nanoemulsions Revenue by Product in 2023
4.9.6 B. Braun Melsungen Nanoemulsions Revenue by Application in 2023
4.9.7 B. Braun Melsungen Nanoemulsions Revenue by Geographic Area in 2023
4.9.8 B. Braun Melsungen Recent Development
5 Breakdown Data by Type
5.1 Global Nanoemulsions Revenue by Type (2019-2024)
5.2 Global Nanoemulsions Revenue Forecast by Type (2025-2030)
5.3 Nanoemulsions Revenue 麻豆原创 Share by Type (2019-2030)
6 Breakdown Data by Application
6.1 Global Nanoemulsions Revenue by Application (2019-2024)
6.2 Global Nanoemulsions Revenue Forecast by Application (2025-2030)
6.3 Nanoemulsions Revenue 麻豆原创 Share by Application (2019-2030)
7 North America
7.1 North America Nanoemulsions 麻豆原创 Size YoY Growth 2019-2030
7.2 North America Nanoemulsions 麻豆原创 Facts & Figures by Country (2019-2030)
7.3 North America Nanoemulsions Revenue by Type (2019-2024)
7.4 North America Nanoemulsions Revenue by Application (2019-2024)
8 Asia-Pacific
8.1 Asia-Pacific Nanoemulsions 麻豆原创 Size YoY Growth 2019-2030
8.2 Asia-Pacific Nanoemulsions 麻豆原创 Facts & Figures by Region (2019-2030)
8.3 Asia-Pacific Nanoemulsions Revenue by Type (2019-2024)
8.4 Asia-Pacific Nanoemulsions Revenue by Application (2019-2024)
9 Europe
9.1 Europe Nanoemulsions 麻豆原创 Size YoY Growth 2019-2030
9.2 Europe Nanoemulsions 麻豆原创 Facts & Figures by Country (2019-2030)
9.3 Europe Nanoemulsions Revenue by Type (2019-2024)
9.4 Europe Nanoemulsions Revenue by Application (2019-2024)
10 Latin America
10.1 Latin America Nanoemulsions 麻豆原创 Size YoY Growth 2019-2030
10.2 Latin America Nanoemulsions 麻豆原创 Facts & Figures by Country (2019-2030)
10.3 Latin America Nanoemulsions Revenue by Type (2019-2024)
10.4 Latin America Nanoemulsions Revenue by Application (2019-2024)
11 Middle East and Africa
11.1 Middle East and Africa Nanoemulsions 麻豆原创 Size YoY Growth 2019-2030
11.2 Middle East and Africa Nanoemulsions 麻豆原创 Facts & Figures by Country (2019-2030)
11.3 Middle East and Africa Nanoemulsions Revenue by Type (2019-2024)
11.4 Middle East and Africa Nanoemulsions Revenue by Application (2019-2024)
12 Supply Chain and Sales Channel Analysis
12.1 Nanoemulsions Supply Chain Analysis
12.2 Nanoemulsions Key Raw Materials and Upstream Suppliers
12.3 Nanoemulsions Clients Analysis
12.4 Nanoemulsions Sales Channel and Sales Model Analysis
12.4.1 Nanoemulsions Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Nanoemulsions Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Nanoemulsions Distributors
13 麻豆原创 Dynamics
13.1 Nanoemulsions Industry Trends
13.2 Nanoemulsions 麻豆原创 Drivers
13.3 Nanoemulsions 麻豆原创 Challenges
13.4 Nanoemulsions 麻豆原创 Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

Companies Mentioned:

Allergan plc
AbbVie Inc.
AstraZeneca Inc.
Fresenius Kabi AG
Kaken Pharmaceutical
GlaxoSmithKline
Novartis AG
Sanofi
B. Braun Melsungen

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.